Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders
- PMID: 17549501
- DOI: 10.1007/s00401-007-0238-1
Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders
Abstract
Recently, we showed that NUB1 is a synphilin-1-interacting protein and that NUB1, as well as synphilin-1, accumulates in Lewy bodies in Parkinson's disease (PD) and dementia with Lewy bodies (DLB), and glial cytoplasmic inclusions in multiple system atrophy (MSA). In this study, an investigation was further conducted to elucidate the immunohistochemical localization of NUB1 in various neurodegenerative disorders. In controls, anti-NUB1 antibody weakly immunolabeled neuronal perikarya. In PD and DLB, cortical and brainstem-type Lewy bodies, pale bodies and Lewy neurites were strongly immunolabeled with anti-NUB1. In MSA, NUB1 immunoreactivity was found in the intracytoplasmic inclusions of both neuronal and oligodendroglial cells, neuronal nuclear inclusions, and swollen neurites. No NUB1 immunoreactivity was found in a variety of other neuronal or glial inclusions in other disorders, including Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, motor neuron disease and triplet-repeat diseases. These findings indicate that the abnormal accumulation of NUB1 is specific for alpha-synucleinopathy lesions. However, yeast two-hybrid assay demonstrated that NUB1 did not directly interact with alpha-synuclein.
Similar articles
-
Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders.Acta Neuropathol. 2002 Mar;103(3):209-14. doi: 10.1007/s004010100451. Epub 2001 Oct 16. Acta Neuropathol. 2002. PMID: 11907799
-
Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.J Neuropathol Exp Neurol. 2007 Nov;66(11):1019-26. doi: 10.1097/nen.0b013e31815885ad. J Neuropathol Exp Neurol. 2007. PMID: 17984683
-
Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders.Neuropathol Appl Neurobiol. 2005 Feb;31(1):53-61. doi: 10.1111/j.1365-2990.2004.00603.x. Neuropathol Appl Neurobiol. 2005. PMID: 15634231
-
Neuropathological spectrum of synucleinopathies.Mov Disord. 2003 Sep;18 Suppl 6:S2-12. doi: 10.1002/mds.10557. Mov Disord. 2003. PMID: 14502650 Review.
-
Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.J Neurochem. 2007 Oct;103(1):17-37. doi: 10.1111/j.1471-4159.2007.04764.x. Epub 2007 Jul 10. J Neurochem. 2007. PMID: 17623039 Review.
Cited by
-
Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions.Transl Neurodegener. 2020 Feb 17;9:7. doi: 10.1186/s40035-020-0185-5. eCollection 2020. Transl Neurodegener. 2020. PMID: 32095235 Free PMC article. Review.
-
Role of Ser129 phosphorylation of α-synuclein in melanoma cells.J Cell Sci. 2013 Jan 15;126(Pt 2):696-704. doi: 10.1242/jcs.122093. Epub 2012 Nov 30. J Cell Sci. 2013. PMID: 23203798 Free PMC article.
-
NEDD8 ultimate buster-1 long (NUB1L) protein promotes transfer of NEDD8 to proteasome for degradation through the P97UFD1/NPL4 complex.J Biol Chem. 2013 Oct 25;288(43):31339-49. doi: 10.1074/jbc.M113.484816. Epub 2013 Sep 9. J Biol Chem. 2013. PMID: 24019527 Free PMC article.
-
α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies.Front Neurosci. 2025 Mar 27;19:1570553. doi: 10.3389/fnins.2025.1570553. eCollection 2025. Front Neurosci. 2025. PMID: 40212715 Free PMC article. Review.
-
Synphilin-1-binding protein NUB1 is colocalized with nonfibrillar, proteinase K-resistant α-synuclein in presynapses in Lewy body disease.J Neuropathol Exp Neurol. 2011 Oct;70(10):879-89. doi: 10.1097/NEN.0b013e3182303745. J Neuropathol Exp Neurol. 2011. PMID: 21937912 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical